Cyclooxygenase-2 Inhibitors in Inflammation and Cancer (Q169000): Difference between revisions

From geokb
(‎Created a new Item: Added new OpenAlex topic claimed by USGS staff from API)
 
(‎Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1)
description / endescription / en
This cluster of papers focuses on the use of cyclooxygenase-2 (COX-2) inhibitors, such as rofecoxib, celecoxib, and naproxen, in the context of inflammation and cancer
"Research on medications that block COX-2 enzyme to reduce inflammation and cancer risk."

Revision as of 14:48, 30 August 2024

"Research on medications that block COX-2 enzyme to reduce inflammation and cancer risk."
  • Cyclooxygenase-2 Inhibitors
  • Inflammation
  • Cancer
  • Prostaglandins
  • NSAIDs
  • Cardiovascular Risk
  • Colorectal Cancer
  • Chemoprevention
  • Prostaglandin E2
  • COX-2
Language Label Description Also known as
English
Cyclooxygenase-2 Inhibitors in Inflammation and Cancer
"Research on medications that block COX-2 enzyme to reduce inflammation and cancer risk."
  • Cyclooxygenase-2 Inhibitors
  • Inflammation
  • Cancer
  • Prostaglandins
  • NSAIDs
  • Cardiovascular Risk
  • Colorectal Cancer
  • Chemoprevention
  • Prostaglandin E2
  • COX-2

Statements